| Date |
Time |
Source |
Heading |
|---|
| 6/03/2024 | 16:30 | EDGAR2 | Form DEF 14A - Other definitive proxy statements |
| 5/31/2024 | 08:00 | BW | Azitra, Inc. Announces Presentation at the 2024 BIO.. |
| 5/24/2024 | 16:55 | EDGAR2 | Form PRE 14A - Other preliminary proxy statements |
| 5/17/2024 | 08:00 | BW | Azitra, Inc. Announces Positive Preclinical Data from ATR-04.. |
| 5/10/2024 | 08:00 | BW | Azitra, Inc. Announces Positive Preclinical Data of ATR-12.. |
| 5/09/2024 | 17:05 | EDGAR2 | Form 8-K - Current report |
| 5/09/2024 | 17:03 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 5/09/2024 | 17:00 | BW | Azitra, Inc. Announces Q1 2024 Financial Results and.. |
| 4/22/2024 | 16:30 | BW | Azitra, Inc. Announces New Preclinical Data to be Presented.. |
| 4/18/2024 | 16:15 | BW | Azitra, Inc. to Present New Data at Three Upcoming.. |
| 3/15/2024 | 16:15 | BW | Azitra, Inc. Announces Full Year 2023 Financial Results and.. |
| 2/26/2024 | 16:10 | EDGAR2 | Form SC 13G/A - Statement of acquisition of beneficial.. |
| 2/26/2024 | 16:05 | EDGAR2 | Form SC 13G - Statement of acquisition of beneficial.. |
| 2/16/2024 | 16:05 | BW | Azitra, Inc. Announces Closing of Public Offering |
| 2/15/2024 | 20:42 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/15/2024 | 20:39 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/15/2024 | 20:38 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 2/15/2024 | 16:44 | EDGAR2 | Form 424B5 - Prospectus [Rule 424(b)(5)] |
| 2/14/2024 | 09:15 | EDGAR2 | Form 8-K - Current report |
| 2/13/2024 | 22:09 | BW | Azitra, Inc. Announces Pricing of Public Offering |
| 1/19/2024 | 11:08 | EDGAR2 | Form FWP - Filing under Securities Act Rules 163/433 of free.. |
| 1/19/2024 | 09:19 | EDGAR2 | Form S-1 - General form for registration of securities under.. |
| 1/16/2024 | 09:00 | BW | Azitra, Inc. Strengthens Intellectual Property Portfolio.. |
| 1/03/2024 | 09:00 | BW | Azitra, Inc. to Present at Biotech Showcase 2024 and the.. |
| 12/04/2023 | 16:06 | EDGAR2 | Form S-8 - Securities to be offered to employees in employee.. |
| 11/14/2023 | 16:30 | BW | Azitra, Inc. Announces Third Quarter 2023 Financial Results.. |
| 10/16/2023 | 08:00 | BW | Azitra to Present at the ThinkEquity Conference |
| 10/03/2023 | 16:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/03/2023 | 16:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/03/2023 | 16:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 10/03/2023 | 16:05 | EDGAR2 | Form 4 - Statement of changes in beneficial ownership of.. |
| 8/29/2023 | 08:00 | PRNUS | Azitra to Present at the H.C. Wainwright 25th Annual Global.. |
| 8/14/2023 | 16:11 | EDGAR2 | Form 8-K - Current report |
| 8/14/2023 | 16:10 | EDGAR2 | Form 10-Q - Quarterly report [Sections 13 or 15(d)] |
| 8/14/2023 | 16:05 | PRNUS | Azitra, Inc. Announces Second Quarter 2023 Financial Results.. |
| 7/19/2023 | 16:05 | PRNUS | Azitra Adds Biotech Leaders Barbara Ryan and John Schroer to.. |
| 7/11/2023 | 16:05 | EDGAR2 | Form 8-K - Current report |
| 7/11/2023 | 16:05 | PRNUS | Azitra, Inc. Appoints Travis Whitfill as Chief Operating.. |
| 7/07/2023 | 16:05 | EDGAR2 | Form 8-K - Current report |
| 7/03/2023 | 15:04 | EDGAR2 | Form SC 13D - General statement of acquisition of beneficial.. |
| 6/29/2023 | 16:56 | EDGAR2 | Form 4/A - Statement of changes in beneficial ownership of.. |
| 6/21/2023 | 18:46 | PRNUS | Azitra, Inc. Announces Closing of Initial Public Offering |
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
